Special Issue "Functional Polymeric Nanoparticles"
Deadline for manuscript submissions: 30 June 2022.
Interests: Nanomaterials, nanomedicine, polymeric nanoparticles, nanocapsules, drug delivery, targeted therapy, passive, active and physical targeting, theranostics, imaging, metallic nanoparticles, layer by layer, anticancer therapy, neurodegenerative disorders, physical chemistry, surface modification
Continued advancements in nanotechnology are expanding the boundaries of medical research, most notably as a drug delivery system for anticancer treatment. Application of nanotechnology in the delivery of therapeutic as well as imaging agents can offer greater control over their biodistribution, usually toxic compounds, to improve the therapeutic index. Controlling materials at the nanoscale offers the opportunity to develop medicines with precisely engineered functions in the body. The design of the majority of therapeutic and imaging agents delivery system hugely relies on nanoparticles. Because nanoparticles can exhibit high surface to volume ratios, unique optical properties, tunable shapes, and/or modifiable surfaces, they provide a mechanism for controlling the transport of various therapeutic cargo, within the body, both temporally and spatially.
The application of nanoscale materials in medicine, generally termed nanomedicine, has become mainstream. Nanomedicine is a field of research with huge expectations for the development of personalized medicine based on new nanoparticles. The use of nanoparticles in targeted drug delivery may overcome many intractable health challenges.
We invite researchers to contribute original and review articles regarding the functional polymeric nanoparticles. Potential topics include, but are not limited to: synthesis, modification, and functionalization of nanoparticles, encapsulation of actives, nanoparticles’ characterization and characterization methods, application of nanoparticles as drug carriers, targeted drug delivery systems, passive, active and physical targeting theranostics, formulating new nanomaterials, in vitro and in vivo studies on nanoparticulate systems.
Dr. Krzysztof Szczepanowicz
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Nanomaterials is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- polymeric nanoparticles
- drug delivery
- targeted therapy
- active and physical targeting